Across Spain, more women are speaking openly about menopause, describing symptoms that disrupt daily routines and affect emotional well-being. Many report mental fog and mood swings, along with physical discomfort that caught them unprepared. The World Health Organization describes menopause as a normal biological transition whose effects vary between individuals, and says it can affect temperature regulation and sleep, as well as skin and mucous membranes. It can also affect mood and memory, with cognitive function at stake. As women share their experiences, they often point to a lack of practical guidance and support.
Personal accounts from different regions describe insomnia and irritability, along with fatigue and hot flashes, as common symptoms. Some women, like Laura, struggle with memory lapses and unpredictable mood changes; others, including Marta, describe the emotional toll and anxiety that can arise without a clear cause. For many, these issues extend beyond the home, affecting relationships and performance at work. A survey of 4,000 women cited by La Vanguardia found that about half said menopause had affected their professional lives, while four in ten reported an effect on their work performance. Fatigue or low energy was reported by 81.3%. Nervousness or anxiety, including irritability, was reported by 77.5%, while 76% reported difficulty concentrating or remembering. These are survey findings, not estimates of how common the symptoms are among all women in Spain.
Medical professionals are also seeing more women seeking help for menopause-related problems. Silvia P. González, president of the Asociación Española para el Estudio de la Menopausia, says a impressive portion of patients report mental fog and decreased desire, while about a quarter experience symptoms severe enough to affect their quality of life. González argues that perimenopause and the first decade after menopause offer an impressive chance for prevention: actions during this period, she says, can influence later bone and cardiovascular health, as well as quality of life. A minority go through menopause with few or no symptoms, but many face challenges that merit attention and, in some cases, medical intervention.
The range of reported effects reaches beyond hot flashes and night sweats. A report by La Vanguardia describes sleep disruption and cognitive difficulties, as well as changes in body composition and weakened bones. It also cites reduced strength and dry eyes and vagina, along with hair loss and genitourinary problems. The report says a study published in Science associated menopause with as many as 72 symptoms, though no individual woman necessarily experiences all of them. Ana Fernández-Arcos, a member of the scientific committee of the Sociedad Española de Sueño, has warned that less familiar symptoms may go unrecognized when research and specialist expertise are scarce. She also notes that sleep problems can be among the most disabling menopausal symptoms.
Social media has become a basic platform for sharing experiences and advice, but it has also brought conflicting opinions and information. Influencers and online communities offer support, yet the volume of advice can be overwhelming and sometimes unreliable. The WHO has called for high-quality, long-term research into the safety and effectiveness of different interventions, a need that reinforces the importance of distinguishing established clinical guidance from unsupported claims.
Despite growing awareness, many women still feel menopause is neglected in medical research and public discussion. Some express frustration with limited treatment options and the perception that women's health issues receive less attention. Others say cultural attitudes contribute to a sense of invisibility, though more women are now speaking out. Spanish women's-health experts have called for dedicated menopause consultations in basic-care centers, describing menopause as a stage that needs integrated care and individualized follow-up.
In Spain, menopause typically occurs between the ages of 45 and 55 and affects millions of women. The Spanish healthcare system offers treatments including menopausal hormone therapy, but access and awareness remain uneven. A 2026 clinical review in the Journal of Clinical Endocrinology & Metabolism identifies hormone therapy as the most effective treatment for vasomotor and other estrogen-deficiency symptoms. It supports individualized decisions that weigh symptoms and age, while also accounting for time since menopause and treatment formulation. Personal risk factors matter too. International guidance generally supports considering therapy for bothersome symptoms in women younger than 60 or within ten years of natural menopause onset; this is not universal eligibility, and personal medical history and contraindications matter. Separately, the Spanish medicines agency and affected scientific societies have discussed a temporary supply situation concerning menopause-related medicines, with efforts reported to restore availability.
Medical societies have made increased efforts in recent years to provide accurate information and resources, yet many women still report feeling unprepared for the transition. The debate points to better education and more research, alongside greater societal recognition of menopause as a impressive health issue.
